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ABSTRACT 
Purpose: To evaluate the reproducibility and diagnostic accuracy of "real 
time" Shear Wave Elastography in the measurement of liver stiffness in 
patients with chronic viral hepatitis B and C and in a group of healthy 
volunteers.  
Materials and methods: A consecutive series of patients with chronic viral 
hepatitis B and C and a group of healthy volunteers were evaluated. Patients 
with chronic liver disease underwent liver biopsy. The degree of liver fibrosis 
was assessed according to the METAVIR "score system". Measurements of 
liver stiffness were performed by an experienced radiologist (observer 1) and 
two less experienced radiologists (observers 2 and 3).  Measurements were 
made by each observer in least three different  points of liver parenchyma. In 
each patient, were acquired 12 consecutive measurements for a total time 
acquisition of about 5-10 minutes per patient by using iU22 ultrasond system 
(Philips Medical Systems) with a dedicated convex probe. The degree of liver 
stiffness measured in kPa was recorded and displayed automatically at the 
end of each measurement. The results of the "real time" Shear Wave 
Elastography evaluation, corresponding to the average of 12 measurements, 
were displayed at the end of each measuremet. They evaluated 57 patients 
with chronic liver disease and 37 healthy volunteers (50 males and 44 
females, aged between 19 and 80 years). The average value of the 
measurements were of 9.7 kPa in patients with chronic liver disease and 5.5 
kPa in the group of healthy volunteers.  
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Results: The "real time" Shear Wave Elastography measurements showed a 
good correlation with the results of the biopsy relatively to the stage of 
fibrosis (p <0.001). An excellent reproducibility was observed in 
measurements between the three observers (ICC, 0.85; 95% confidence 
interval: 0.70 to 0.94).  
Conclusion: The "real time" Shear Wave Elastosography showed to be a 
reproducible method and accurate in measuring the stiffness of the liver 
parenchyma in patients with chronic liver desease and in the group of healthy 
volunteers. Healthy volunteers showed significantly lower values with 
respect to patients with chronic liver desease. 
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INTRODUCTION 
 
Patients with chronic viral hepatitis B and C are at increased risk of cirrhosis. 
Assessment of fibrosis has important prognostic implications that guide 
clinical therapy (1,2). The prognosis and management of chronic viral 
hepatitis depend on the extent and progression of liver fibrosis, which 
constitute the most important predictor of disease outcome and influence the 
indication for antiviral treatment (3).  
Though liver biopsy is still the reference standard for diagnosis and grading 
of fibrosis, it is invasive and carries risk of complications.  
In the last decade, methods to noninvasively quantify liver fibrosis have been 
developed. The first available method was Transient Elastography (4). 
Several studies have demonstrated a high accuracy of Transient Elastography 
in identifying significant fibrosis (F > 2) and cirrhosis (F = 4) in patients with 
chronic viral hepatitis (5-9).  
The recent guidelines for the management of viral hepatitis  infection from 
the European Association for the Study of the Liver allow the use of 
Transient Elastography, instead of liver biopsy, in patients with chronic viral 
hepatitis for assessing liver disease severity prior to therapy at a safe level of 
predictability (10). Transient Elastography has been approved by the French 
National Health Authority for the evaluation of fibrosis in treatment-naïve 
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patients with chronic viral hepatitis  and no comorbidities (11).  
Shear Wave Elastography techniques have been implemented in conventional 
real-time ultrasound systems, and several studies have shown their accuracy 
in the assessment of liver fibrosis (12-16). Compared with Transient 
Elastography, these techniques have the advantage of B-mode image 
guidance; thus, they can allow the user to choose the best acoustic window 
for correctly performing an examina- tion in real time. 
Magnetic Resonance (MR) Elastography is based on the use of Shear Wave 
Elastography induced in tissues by external surface vibrators. MR 
Elastography also showed promising results for quantification of liver 
fibrosis with high accuracy (17-19). However, MR Elastography has some 
limitations. It is imprecise for detection of early levels of fibrosis and for 
quantitation of intermediate levels of fibrosis. There is overlap between 
adjacent stages of fibrosis, especially in the precirrhotic stage of liver disease. 
The difference is small in grade F0–F2 fibrosis, but it is larger in grades F3 
and F4 (19,20). The acquisition time for MR Elastography is long (10–15 
minutes), and therefore it is limited to static organs and precludes freehand 
applicability (21). Technically, the delivery of Shear Wave Elastography by 
MR Elastography into the abdomen may be imperfect, and it may lead to 
error in interpretation and calculation (20).  
Shear Wave Elastography allows absolute quantification of tissue stiffness in 
terms of pressure unit of kilopascals versus a semiquantitative estimate that 
corresponds to relative tissue strain (22).   
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The aim of this study was to estimate the validity of Shear Wave 
Elastography by evaluating the reproducibility and the accuracy of this 
method in the measurement of liver stiffness in patients with chronic viral 
hepatitis B and C and in a group of healthy volunteers.  
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MATERIALS AND METHODS 
 
Between January 2014 and March 2015, 94 consecutive patients (50 males 
and 44 females, aged between 19 and 80 years) were included in the study. 
Fifty-seven patients were suffering from chronic viral hepatitis histologically 
proven (B=22 and C=35), and the remaining 37 patienys were healthy 
volunteers. 
Patients with chronic hepatitis B or C virus induced did not receive antiviral 
therapy or antifibrotic. The assessment excluded patients with hepatocellular 
carcinoma with hepatic insufficiency or with ascites. Patients whose 
elastosonographic measurements were not satisfactory or patients who 
refused to undergo liver biopsy were also excluded. The patients underwent 
liver biopsy within 12 months of elastosonographic evaluation. A recent 
study has shown that a delay between the liver biopsy and the 
elastosonographic evaluation of about 15 months is acceptable because the 
expected changes in the level of the liver parenchyma are minimal (23).  
The group of healthy volunteers did not present a significant past medical 
history, including diabetes or hypertension. They did not show a high intake 
of alcohol (defined as <30 g of alcohol per day for men and <20 g for 
women), presented negative serological tests for hepatitis B and hepatitis C 
and did not present biochemical or ultrasound findings typical for liver 
disease. They did not make chronic use of drugs or substance abuse. Healty 
volunteers whose elastosonographic measurements were unsatisfactory were 
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excluded from the evaluation. 
None of the observers was made aware of the clinical data of patients and of 
their “real time” Shaer Wave Elastography results. 
Elastosonographics measurements were made using the iU22 ultrasound 
system (Philips Medical System) with a dedicated convex probe. The 
elastosonographic evaluation was performed at the end of each ultrasound 
and ultrasound color Doppler examination. In all cases, the measurements 
were carried out at the level of the liver parenchyma of employing a right 
intercostal approach, since a subcostal approach is not always feasible. In 
addition, the intercostal approach results in less external compression on the 
liver parenchyma (4). Patients were instructed to maintain a steady breathing 
that was made at the time of measurement block to avoid breathing artifacts. 
The measurements were carried out at a depth between 20 and 50 mm, 
identifying an area not contiguous to the main intrahepatic vascular 
structures. The evaluation included at least 12 correct measurements per 
patient with a total acquisition time of about 5-10 minutes. The degree of 
liver stiffness measured in kPa was recorded and displayed automatically 
after each correct measurement as well as the evaluation results 
corresponding to the average of 12 measurement (Fig. 1). 
Measurements below 1 kPa were not recorded by the observers. The three 
observers made a specific training before starting the enrollment of the 
patients.  
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Liver biopsy was performed in outpatients under ultrasound guidance after 
mild local  anelgesia at the level of the right hepatic lobe and frustules were 
sent for reading to the same pathologist. The degree of liver fibrosis was 
assessed according to the METAVIR "score system" that includes five 
stages: F0, no fibrosis; F1, early fibrosis (portal fibrosis without septa); F2, 
moderate fibrosis (portal fibrosis with few septa); F3, severe fibrosis 
(numerous septa without cirrhosis); and F4, cirrhosis (24) (Fig. 2) 
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RESULTS  
 
The “real time” Shear Wave Elastosonographic evaluation of the hepatic 
parenchyma had technical success in 90/94 patients (96%). The technical 
failure in four patients was due in two patients to the fact that the intercostal 
space was too narrow to obtain an optimal scan window for  correct 
measurements and in two patients to the fact that they could not hold a proper 
breathing at the time of measurements. In the group of healthy volunteers, the 
mean values of the measurements of liver parenchyma were 5.5 ± 0.7 kPa 
(standard deviation) with a range of 3.7 to 6.7 kPa. Males showed 
significantly higher values than females (respectively 5.7 kPa ± 0.5 vs 5.4 ± 
0.7 kPa; P = 0.02) (Fig. 3). 
In the group of patients with chronic viral  hepatitis B or C, the average 
values of measurements liver parenchyma ranged between 4.3 and 40.5 kPa 
(Fig. 4). 
The elastosonographic evaluation of the liver parenchyma showed a good 
correlation with the results of the biopsy relatively to the stage of fibrosis (p 
<0.001). Measurements of liver parenchyma showed some overlap between 
degrees F0 and F1, while a clear distinction between the degrees F2 (P = 
0.002), F3 (P = 0.1) and F4 (P = 0.001). The evaluation of liver parenchyma 
showed overall diagnostic accuracy of 86% - 98% and a specificity of 90% -
93%. In 3 cases a discrepancy was documented between the given 
elastosonographic and the bioptic results. In two cases, the elastosonographic 
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evaluation underestimated the degree of fibrosis by one stage; in one case, 
the elastosonographic evaluation overestimated the degree of fibrosis by one 
stage. Finally, an excellent reproducibility was observed in the measurements 
between the three observers (ICC, 0.85; 95% confidence interval: 0.70 to 
0.94) (Fig. 5). 
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DISCUSSION 
Patients with chronic viral hepatitis B and C are at high risk of developing 
liver cirrhosis. The evaluation of fibrosis has important prognostic and 
therapeutic implications (25,2). Although the liver biopsy still represents the 
gold standard method for the diagnosis and staging of fibrosis and cirrhosis 
of the liver, it is an invasive approach that is associated to a significant risk of 
complications. Liver biopsy, is also not a perfect method for the surveillance 
of this patient population. 
The ultrasound elastography methods have been recently introduced in the 
clinical practice. They measure the elasticity of tissue non-invasively. They 
are based on the compression of the tissue examined which produces a 
displacement/distortion within the same tissue, with subsequent calculation 
of the profile of the deformation along the axis of compression; the profile of 
displacement/distortion represents the distribution of elasticity of the tissue 
examined and consequently its degree of greater or lesser elasticity and is 
generally expressed in kPa (Fig. 6). Elastosonographics techniques are 
proposed as an alternative to liver biopsy for diagnosis and staging the degree 
of liver fibrosis and its surveillance. In particular, the Transient Elastography, 
the “real time” Share Wave Elastography and the “real time” Acoustic 
Radiation Force Impulse are currently the three techniques of greater use in 
direct and indirect measurement of liver stiffness, ie the degree of liver 
fibrosis (26-30). Among these techniques, the Fibroscan is the one used by 
more time in the clinical pratice with unreliable results in 15.8% of cases 
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(31). 
This study was undertaken to assess the validity of  “real time” Share Wave 
Elastography, i.e., the reproducibility and accuracy of measurements of this 
method.  
While ultrasound elastosonographic imaging is now widely recognized as a 
reliable method to assess liver fibrosis, various techniques that use Transient 
Elastography imaging are imprecise for detection of early and intermediate 
levels of fibrosis (2,24,32). Previous studies reported high accuracy with 
transient elastography only for detection of the more advanced fibrosis stages 
F3 and F4 (33). Other results show that “real time” Share Wave Elastography 
is a highly reproducible method for assessing liver stiffness because it was 
characterized by very high levels of intraobserver and interobserver 
agreement, both overall and for single measurements. Moreover, the 
reproducibility of the method was similar in healthy subjects and in patients 
with chronic viral hepatitis. Ultrasound imaging techniques are subject to 
user dependency. Nevertheless, good interobserver agreement rates have 
been reported for Shear Wave Elastography, suggesting that the method itself 
has low variability and requires only a short period of training to be 
performed reliably (34-36). Indeed, the benefits of image guidance will likely 
reduce the learning curve and the variations between measurements (36).  
The results of this study show that “real time” Shear Wave Elastography 
results are directly and linearly correlated with the stages of fibrosis 
determined using histology.  
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The diagnostic accuracy of “real time” Shear Wave Elastography was similar 
to that reported by some other studies, which used a different Shear Wave 
Elastography method that also included Acoustic Radiation Force Impulse.  
Rizzo et al (14) found that Acoustic Radiation Force Impulse was more 
accurate than Transient Elastography for the staging of both significant and 
severe liver fibrosis. However, those results were not confirmed by a recent 
meta-analysis that compared Acoustic Radiation Force Impulse with 
Transient Elastography and found comparable diagnostic accuracies of both 
methods for the diagnosis of severe fibrosis and a slightly but significantly 
higher diagnostic accuracy of Transient Elastography for the diagnosis of 
significant fibrosis and cirrhosis (15).  
“Real time” Shear Wave Elastography is a recently developed method that is 
part of second generation ultrasound elastography methods.  
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CONCLUSION 
In conclusion "real time" Shear Wave Elastosography showed to be a 
reproducible method and accurate in measuring the stiffness of the liver 
parenchyma in patients with chronic liver desease and in the group of healthy 
volunteers. Healthy volunteers showed significantly lower values with 
respect to patients with chronic liver desease. 
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Figures 
1) An example of final screenshot at the end of procedure 
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2) Metavir Score System 
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3) Liver stiffness in female and in male patients 
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4) Liver stiffness values in patient with chronic viral B liver disease 
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5) “Real time” Share Wave Elastography vs. bioptic findings 
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6) Share Wave Elastography Imaging Analysis and its  propagation 
map 
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